Twitter LinkedIn
    Wednesday, July 6
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Acquisitions»Medmen Enterprises Inc. Announce $100 Million Private Equity Investment And Tilray Inc. Acquires Stake in MedMen
    Acquisitions

    Medmen Enterprises Inc. Announce $100 Million Private Equity Investment And Tilray Inc. Acquires Stake in MedMen

    August 26, 20212 Mins Read
    LinkedIn Facebook Twitter Email WhatsApp
    Marijuana leaves in the hands of a medical team Medical background. The concept of oil refining to treat diseases. alternative medicine Natural herbs used to treat diseases.
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Medmen Enterprises Inc. (OTCMKTS: MMNF) has announced that various investors, spearheaded by Serruya Private Equity, will purchase around $100 million worth of its units at $0.24 per unit.

    The company will use the $100 million raised from the Private Placement to expand operations in major markets such as Florida, Illinois, California, and Massachusetts and expedite growth opportunities in the US.

    MedMen CEO Tom Lynch said, “This US$100 million investment is a game-changer for our Company, strengthening our balance sheet and creating a platform for our future growth. This transaction gives us the flexibility and firepower to match our revenue trajectory to our operational expertise and internationally renowned brand. MedMen 2.0 is here, and we are thrilled to embark on the next stage of our journey.”

    Among the investors that bought a stake in the amended convertible Note is Tilray Inc. (NASDAQ: TLRY). Tilray purchases the note originally held by Funds, including Gotham Green Partners LLC. After the legalization of cannabis in the US, Tilray will convert the Notes and exercise the related warrants to gain a significant ownership stake in MedMen.

    Tilray CEO Irwin Simon said, “Backed by accelerating trends towards legalization globally, we are focused on building the world’s leading cannabis-focused consumer-branded company with a goal of $4 billion of revenue by the end of our fiscal 2024. The investment we are announcing in MedMen securities today, one of the most recognized brands in the $80 billion U.S. cannabis market, is a critical step towards delivering on our objective as we work to enable Tilray to lead the U.S. market when legalization allows.”

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Acquisition Deals Transactions Investments peinsider Private Equity uncategorized
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Clearlake Capital and Motive Partners complete acquisition of BETA+ from LSEG

    July 5, 2022

    Biosynth Carbosynth acquires KKR’s Pepscan

    July 5, 2022

    Triton to tap €5.2bn Fund V for OCU buyout

    July 5, 2022

    Private lenders are offering cheaper debt than Wall Street banks

    July 5, 2022

    Comments are closed.

    Other Articles

    Nigeria’s Flutterwave reaches $3bn valuation after $250mn fundraising

    February 16, 2022

    Thoma Bravo’s $12.3 billion purchase of Proofpoint is the largest private equity cloud deal

    April 27, 2021

    Schroders Capital to manage €100m multi-private assets impact portfolio for Barmenia

    April 22, 2022

    Micro-satellite specialist Umbra raise USD32m in venture funding

    February 16, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?